PO-1336 Salvage HDR brachytherapy for localised recurrent prostate cancer after primary irradiation. (August 2021) - Stankiewicz, M.; Wojcieszek, P.; Lelek, P.; Krzysztofiak, T.; Kellas-Sleczka, S.